BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:RAPA-201 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of RAPA-201\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06708455-2697@assetmemo.bio
DTSTAMP:20261121T004533Z
DTSTART;VALUE=DATE:20290301
DTEND;VALUE=DATE:20290302
SUMMARY:RAPA-201: Phase 2 readout est. (NCT06708455)
DESCRIPTION:RAPA-201\, phase 2.\nStudy: Phase 2b of RAPA-201 Cell Therapy i
 n Post-PD-(L)-1 Melanoma\nEstimated primary completion: 1 March 2029. This
  is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it 
 can move.\nDrug page: https://assetmemo.bio/drug/rapa-201#upcoming-events\
 nRegistry record: https://clinicaltrials.gov/study/NCT06708455
URL:https://assetmemo.bio/drug/rapa-201#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
